Professional Documents
Culture Documents
Time
Session
8:309:00AM
CheckIn
Checkin&Greeting
Coffee,pastriesandfruit
Welcome&Intros
Introductoryremarks&welcome
NYCsmultiagencystrategytocombatK2
WhatisK2?Howisitmade?Howlongasitbeen
availableintheUS?
HowdoesK2affectusers?Whatadversehealtheffects
doesitcause?
Howhavethecompoundschangedovertime?
Whatisthescopeoftheproblemnationally?Whathave
welearnedfromthemostrecentoutbreaks?
WhatarethemisperceptionsaboutK2?
Whatarethechallengestoaddressingthepublichealth
threatposedbyK2?
Whatisthescopeofthepublichealthproblemposedby
K2inNYC?(DOHData)
WhoisusingK2inNYC?Howhastheuserpopulation
shiftedovertime?
HowarewetreatingK2usersintheshortandlongterm?
WhataretheongoingeffortstocombatK2fromthe
enforcementandpublicsafetyperspectives?
Howisfederallawenforcementtargetingthe
manufactureanddistributionofK2?Whatarethe
applicablefederalandstatelawsandhowaretheybeing
enforced?
Howisitregulatedlocally?Whatadditionalpenalties
doesthenewcitylawprovideandhowwillitbe
implemented?
9:009:15
AM
Topics
9:1510:00
AM
ImpactofK2on
PublicHealth
10:0010:30
AM
10:30
10:40AM
10:4011:40
AM
Targetingthe
Distributionand
SaleofK2
BREAK
BreakoutSessions
10minBREAK
1.Criminal&CivilEnforcement
WhoissellingK2inNYC?Howisitbeingsold?What
optionsdowehavefortargetingthem?Whatcriminal
chargeshaveandcanbebrought?Whatcivilcharges
haveandcanbebrought?
Whatagenciesarebringingthosecharges?What
additionalenforcementoptionsdoesthenewcitylaw
provide?Howwillthoseenforcementeffortsbe
pursued?
HowdoregulatoryactionsimpactthemarketforK2?
Ischemicaltestingnecessary?Howisthattesting
conducted?
Whatchallengesremaintocriminalandcivil
Speakers
Audience
DCACom.JulieMenin
SpeakerMelissaMarkViverito
ALL
MaryBassettMD,DOHComm
Toxicologist,DEA
HillaryKunins,MD,DOH
ALL
Dir.ElizabethGlazer,MOCJ
JohnScherbenske,DEAChiefof
SyntheticDrug&ChemicalSection
RobMessner,NYPD
ALL
NYPDRep
NYRegionalRep,DEA
KaiFalkenberg,DCA
SheriffJoeFucito,DOF
Prosecutors,judges,law
enforcement,probation&
correctionsofficers
enforcement?
2.BestPracticesforMedicalandPublicSafetyFirst
Responders
HowdoesK2usepresentitselfmedicallyand
psychiatrically?
o Theagitatedpatientpresentationand
management
o Thesedatedpatientspresentationand
management
CaseDiscussion
QandA
3.ChronicCare:TreatmentandHarmReductionApproaches
Whatisknownaboutlongertermuseandconsequences?
Whatarebestpracticesforharmreductionandtreatment
approaches?
WhataresomesamplestrategiesforK2treatment?
Casediscussion
QandA
Dr.AmitRajpariaMD,Bellevue
Hospital
Dr.SandraScottMD,Lincoln
Hospital
EMS/FDNYRep
Physicians,nurses,
emergencymedical
personnel,substanceuse
disorderandmentalhealth
providers,lawenforcement
Dr.LukeBergmann,MD,HHC
Dr.CharlesBarronMD,Officeof
BehavioralHealth,HHC
PeerEducator(TBD)
Healthcareworkers
11:4011:50
AM
BREAK
11:5012:15
PM
Conclusory
Remarks
Testimonials
10minBREAK
ALL
DellaEllis,formerK2Addict
[TBD]
ALL